Abnormal expression of serotonin transporter mRNA in the frontal and temporal cortex of schizophrenics

Molecular Psychiatry

Volumn 2, Issue 1, 1997, Pages 57-64

  Hernandez, I ^a   Sokolov, B P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

mRNA expression; Postmortem brain; Schizophrenia; Serotonin transporter

Indexed keywords

CARRIER PROTEIN; MESSENGER RNA; NEUROLEPTIC AGENT; SEROTONIN; SEROTONIN TRANSPORTER;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN REGION; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; TEMPORAL CORTEX;

EID: 0030897885     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000215     Document Type: Article

References (25)

1. Breier A. Serotonin, schizophrenia and antipsychotic drug action. Schizophrenia Bes 1995; 14: 187-202.
2. Ohuoha DC, Hyde TM, Kleinman JE. The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system. Psyche/pharmacology 1983; 112: S5-S15.
3. Murphy DL. Neuropsychiatrie disorders and the multiple human brain serotonin receptor subtypes and subsystems. Neuropsychopharmacology 1990; 3: 457-71.
4. Sanders-Busch E (ed). The Serotonin Receptors. Humana: Clifton, NJ, 1988.
5. Amara S, Kuhar M. Neurotransmitters transporters: recent progress. Annu Rev Neurosci 1993; 16: 73-93.
6. Kanner B, Schuldiner S. Mechanism of transport and storage of transmitters. CRC Crit Rev Biochem 1987; 22: 1-38.
7. Ramamoorthy S, Bauman AL, Moore KR, Han H, YangFeng T, Chang AS, Ganapathy V, Blakely RD. Antidepressant and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 1983; 90: 2542-2546.
8. Demeter E, Tekes K, Majorossy K, Palkovits M, Soos M, Magyar K, Somogyl E. The asymmetry of 3H-imipramine binding may predict psychiatric illness. Life Sci 1989; 44: 1403-1410.
9. Laruelle M, Abi-Dargham A, Casanova MF, Titi R, Weinberger DR, Kleinman JE. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry 1993; 50: 810-818.
10. Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 1993; 8: 315-336.
11. Dean B, Opeskin K, Pavey G, Naylor L, Hill C, Keks N, Copolov DL. [3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia. J Neurochem 1995; 04: 1197-1202.
12. Akbarian S, Bunney WE, Potkin SG, \Vigal SB, Hagman JO, Sandman CA, Jones E. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 1993; 50: 169-177.
13. Akbarian S, Vinuela A, Kim JJ, Potkin SG, Bunney WE, Sandman CA, Jones E. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 1993; 50: 178-187.
14. Bloom FE. Advancing a neurodevelopmental origin for schizophrenia. Arch Gen Psychiatry 1993; 50: 224-227.
15. Suddath RL, Casanova MF, Goldberg TE, Daniel DG, Kelsoe Jr JR, Weinberger DR. Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. Am J Psychiatry 1989; 146: 464-472.
16. Weinberger DR, Aloia MS, Goldberg TE, Berman KF. The frontal lobes and schizophrenia. J Neuropsychiatry Clin Neurosci 1994; 6: 419-427.
17. Menon RR, Barta PE, Aylward EH, Richards SS, Vaughn DD, Tien AY, Harris GJ, Pearlson GD. Posterior superior temporal gyrus in schizophrenia: grey matter changes and clinical correlates. Schizophr Res 1995; 16: 127-135.
18. Liddle PF, Neurobiology of schizophrenia. Curr Opin Psychiatry 1994; 7: 43-46.
19. Davidson M, Harvey P, Powchik P, Parrella M, White L, Knobler H, Losonczy M, Keefe R, Katz S, Frescska E. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry 1995; 152: 197-206.
20. Chomczynsky P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 172: 156-159.
21. Lesch KP, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL. Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Molec Brain Res 1993; 17: 31-35.
22. Crow TJ, Cross AJ, Cooper SJ, Deakin JFW, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R, Corsellis JAN, Chambers DR, Blessed G, Perry EK, Pery EH. Neurotransmitter receptors and monoamine metabolites in the patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 1984; 23: 1561-1569.
23. Gross-Isseroff R, Israel M, Biegon A. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effect of suicide. Arch Gen Psychiatry 1989; 46: 237-241.
24. Stanley M, Virgilio J, Gershon S. Tritiated imipramine binding sites in the frontal cortex of suicides. Science 1982; 216: 1337-1339.
25. Stanley M, Mann JJ. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1983; 1: 214-216-